We also found that mutations in the cell death modulator DIDO1 (death obliterator-inducer 1) manifest a similar pattern in to CASP8 in head and neck cancer, with DIDO1 mutations associated with higher estimates of natural killer cells. This evidence concerns the gene CASP8 and head and neck cancer.